Literature DB >> 25932085

Posterior reversible encephalopathy syndrome during the peripartum period: report of four cases and review of the literature.

Hasan Buyukaslan1, Ugur Lok2, Umut Gulacti2, Ozgur Sogut3, Halil Kaya1, Tahir Gokdemir1, Oner Yalin4.   

Abstract

Posterior reversible encephalopathy syndrome (PRES) is a cliniconeuroradiologic disorder affecting the brain's occipital and parietal lobes characterized by altered mental status, seizures, headache and blurred vision. Eclampsia is one of the main causes of posterior reversible encephalopathy. We aimed to discuss here literature guided clinical and radiologic findings of four women who had experienced status epilepticus at peripartum period and diagnosed as PRES.

Entities:  

Keywords:  Posterior reversible encephalopathy syndrome; peripartum period; seizure

Year:  2015        PMID: 25932085      PMCID: PMC4402732     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  29 in total

1.  Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions.

Authors:  S O Casey; R C Sampaio; E Michel; C L Truwit
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

2.  Posterior reversible encephalopathy syndrome in early postpartum women: a case report.

Authors:  Vinod Patil S; B R Dhamangaonkar; R C Pattanshetti; M M Patil
Journal:  J Clin Diagn Res       Date:  2014-04-15

3.  Post-dural puncture headache and posterior reversible encephalopathy syndrome: a misdiagnosis or co-presentation?

Authors:  H Doherty; S Hameed; I Ahmed; I F Russell
Journal:  Int J Obstet Anesth       Date:  2014-02-17       Impact factor: 2.603

4.  Posterior reversible encephalopathy syndrome in lung transplantation: 5 case reports.

Authors:  F E Arimura; P C L B Camargo; A N Costa; R H O B Teixeira; R M Carraro; J E Afonso; S V Campos; M N Samano; L M Fernandes; L G Abdalla; P M Pêgo-Fernandes
Journal:  Transplant Proc       Date:  2014 Jul-Aug       Impact factor: 1.066

5.  Blood pressure fluctuations in posterior reversible encephalopathy syndrome.

Authors:  Alejandro A Rabinstein; Jay Mandrekar; Ryan Merrell; Osman S Kozak; Olayemi Durosaro; Jennifer E Fugate
Journal:  J Stroke Cerebrovasc Dis       Date:  2011-05-04       Impact factor: 2.136

6.  Posterior reversible encephalopathy syndrome following measles vaccination.

Authors:  Tadanori Hamano; Tomoko Takeda; Hiroshi Morita; Tomoko Muramatsu; Makoto Yoneda; Hirohiko Kimura; Masaru Kuriyama
Journal:  J Neurol Sci       Date:  2010-09-17       Impact factor: 3.181

7.  The spread of brain oedema in hypertensive brain injury.

Authors:  H Kalimo; K Fredriksson; C Nordborg; R N Auer; Y Olsson; B Johansson
Journal:  Med Biol       Date:  1986

8.  Cerebral perfusion abnormalities in children with central nervous system manifestations of lupus detected by single photon emission computed tomography.

Authors:  I S Szer; J H Miller; D Rawlings; B Shaham; B Bernstein
Journal:  J Rheumatol       Date:  1993-12       Impact factor: 4.666

9.  Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images.

Authors:  Diego J Covarrubias; Patrick H Luetmer; Norbert G Campeau
Journal:  AJNR Am J Neuroradiol       Date:  2002 Jun-Jul       Impact factor: 3.825

10.  Heterogeneity of radiological spectrum in tacrolimus-associated encephalopathy after lung transplantation.

Authors:  Qisi Wu; Christian Marescaux; Xinyue Qin; Romain Kessler; Jun Yang
Journal:  Behav Neurol       Date:  2014-05-27       Impact factor: 3.342

View more
  2 in total

1.  An Unusual Complication following Ventriculoperitoneal Shunting.

Authors:  Joseph Merola; Shailendra Magdum
Journal:  J Pediatr Neurosci       Date:  2017 Jan-Mar

2.  Transient cortical blindness in posterior reversible encephalopathy syndrome after postpartum eclampsia.

Authors:  Antonio Sesar; Ivan Cavar; Anita Pusic Sesar; Irena Sesar
Journal:  Taiwan J Ophthalmol       Date:  2018 Apr-Jun
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.